00570.HK
China Traditional Chinese Medicine Holdings Co. Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.35
+1.89%Sep 4, 2026, 12:48 UTC
China Traditional Chinese Medicine Holdings announced that its subsidiary Tongjitang Pharmaceutical's Class 1.1 innovative traditional Chinese medicine drug Xingpi Jieyu Tablets (formerly Yusuda Tablets) has been approved for market launch by the National Medical Products Administration.
Source:Aug 28, 2026, 13:27 UTC
China Traditional Chinese Medicine Holdings Co Ltd (00570) released its interim results for the six months ended June 30, 2026, reporting a net loss attributable to shareholders of RMB 776 million, a year-on-year increase of 619.3%, and revenue of RMB 5.438 billion, down 27.1% year-on-year.
Source:Jul 24, 2026, 09:26 UTC
China Sino-United announced that its board resolved to use capital reserves and statutory surplus reserves to offset accumulated losses as of December 31, 2025.
Source:Jul 20, 2026, 01:42 UTC
China Traditional Chinese Medicine Co., Ltd. announced that Yang Jun resigned as executive director and chairman of the board due to reaching statutory retirement age, effective immediately, and Guo Jinhong succeeded him.
Source: